Singulus answers shareholder questions ahead of annual meeting
Reuters2026/08/27 08:12- Singulus published proxy Q&A ahead of its shareholder meeting, focusing on agenda item 8 covering Schuldverschreibungen issuance authority.
- Management will table an amended resolution to replace the July 25, 2024 authorization, scrapping Conditional Capital 2024/I in favor of Conditional Capital 2026/I.
- New authority permits Schuldverschreibungen with a total nominal amount up to EUR 50 million, setting the group’s overall permitted debt raise.
- Conditional Capital 2026/I allows up to 4,448,263 new shares to satisfy conversion or option rights, capping potential dilution at that level.
- No immediate share issuance; shares would be created only if conversion or option rights are exercised, including for bonds issued under the 2024 mandate.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
Orora names Susannah Jobling Hodgens chief legal officer, company secretary successor
AirAsia says drug tests for all active pilots, cabin crew return negative results
GE HealthCare (GEHC.US) plans to acquire Sofie for $1 billion, aiming for high growth in the radiopharmaceutical sector
GE Healthcare plans to acquire Sofie for about $1 billion, aiming to expand recurring revenue by combining imaging devices with radiodiagnostic agents, in response to weak stock performance and pressure from activist investors.
Silver Price Forecast: XAG/USD bears have the upper hand below $64.75-$64.85 confluence
Crypto prices
More
